Furthermore, the incidence of TLS within the subset of patients with DLBCL and HGBCL in our cohort aligns closely with an international dataset of DLBCL patients treated with DA‐EPOCH‐R or R‐CHOP.27 The gene discussed is DDIT3; the disease is Tumor Lysis Syndrome.